332
Participants
Start Date
October 15, 2002
Primary Completion Date
October 19, 2011
Study Completion Date
September 19, 2013
prednisone
Given orally
thalidomide
Given orally
Tom Baker Cancer Centre, Calgary
Cross Cancer Institute, Edmonton
BCCA - Vancouver Cancer Centre, Vancouver
CancerCare Manitoba, Winnipeg
The Moncton Hospital, Moncton
Atlantic Health Sciences Corporation, Saint John
Dr. H. Bliss Murphy Cancer Centre, St. John's
QEII Health Sciences Center, Halifax
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
Cancer Centre of Southeastern Ontario at Kingston, Kingston
London Regional Cancer Program, London
Odette Cancer Centre, Toronto
Univ. Health Network-Princess Margaret Hospital, Toronto
Hopital Maisonneuve-Rosemont, Montreal
McGill University - Dept. Oncology, Montreal
CHA-Hopital Du St-Sacrement, Québec
Centre hospitalier universitaire de Sherbrooke, Sherbrooke
Saskatoon Cancer Centre, Saskatoon
Lead Sponsor
National Cancer Institute (NCI)
NIH
Eastern Cooperative Oncology Group
NETWORK
NCIC Clinical Trials Group
NETWORK